CHI Releases Final Agenda for Ninth Annual microRNA Conference

Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development
Spread the Word
Listed Under

* Microrna
* Diagnostics
* Drug Development

* Biotech
* Science

* Needham - Massachusetts - US

Nov. 5, 2012 - PRLog -- Cambridge Healthtech Institute (CHI) is pleased to announce the final agenda for its ninth annual microRNA conference to be held March 4-5, 2013.  Year over year, the program brings together the scientific, academic and technical teams involved in cutting-edge microRNA research.  The 2013 meeting is designed to highlight new strategies and solutions for using miRNAs for health and disease, the novel applications and progress made in manipulating microRNA, and the opportunities for using microRNA as a tool.  Sessions include: Therapeutic Potential in Inflammation, Cancer and Pain; New Technological Strategies; microRNAs as Biomarkers and in Diagnostics; Tissue-Based Analysis and Circulating miRNAs.  New this year is a pre-conference short course covering the Computational Aspects of microRNA.

Among the notable presenters are leading research and development professionals in the field (partial list):

- microRNAs in Diagnostics and Targeting Rheumatic Disease
Steffen Gay, M.D., Professor, Experimental, Rheumatology, University of Zurich

- Causes and Consequences of microRNA Dysregulation in Cancer
Carlo M. Croce, M.D., Professor and Chair, Department of Molecular Virology, Immunology and Medical Genetics; Director, Institute of Genetics, Ohio State University

- Pre-Clinical Development of a Tumor Suppressor miRNA
David Brown, Ph.D., Director, Research, Mirna Therapeutics

- microRNAs: Novel Target Class for Small Molecule Drug Discovery?
Pramod Pandey, Ph.D., Senior Research Investigator, Center for Proteomic Chemistry, Integrated Lead Discovery, Novartis Institute for Biomedical Research, Inc.

- Circulating miRNAs as Biomarkers: How Far Have We Made It?
Igor Mikaelian, M.D., D.V.M., MSc, DACVP, Research Leader, Hoffman-La Roche, Inc.

- Extracting Contextual microRNA Information for Cancer Diagnostics
Lorenzo F. Sempere, Ph.D., Research Assistant, Professor, Department of Medicine, Geisel School of Medicine at Dartmouth

Early registration discounts apply.  The deadline to save is December 7, 2012.

For more information ywluwy and to register, please visit

For sponsorship opportunities, please contact Tim McLucas at 781-972-1342 or

For more information on microRNA and related conferences, please contact Jaime Hodges, at 781-972-5429 or

About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations.  Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.
Posted By:*** Email Verified
Tags:Microrna, Diagnostics, Drug Development
Industry:Biotech, Science
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Like PRLog?
Click to Share